Investment in healthcare has been impacted by the global financial crisis in all markets across Europe. The region accounted for nearly 19% of the global diagnostic imaging market in 2012. Within the mature markets of Western Europe there is a tension between attempting to contain health costs and a desire to increase productivity. In these developed countries hospitals still need to invest to maintain and improve standards of care. Also, with ageing populations, services need to become more efficient to cope with the resulting financial strain. Despite the recession, the majority of countries of Western Europe are continuing to invest, albeit at a slower, more calculated rate.
Like the rest of the world maximum growth has come from ultrasound and X-ray, which lead the market based on sales revenue. Other segments include nuclear medicine imaging, computed tomography (CT) and MRI. The European Diagnostic imaging market is expected to be valued at $6 billion by the 2017. Germany's medical imaging market is the largest of these countries.
What the Report Offers
1. Market Definition for the European Diagnostic market along with identification of key drivers and restraints for the market.
2. Market analysis for the European diagnostic Market, with region specific assessments and competition analysis on a global and regional scale.
3. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4. Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
5. Identification and analysis of the Macro and Micro factors that affect the market on both global and regional scale.
6. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.